First-Ever Guidelines Established for Treatment of Hypoactive Sexual Desire Disorder in Women

First-Ever Guidelines Established for Treatment of Hypoactive Sexual Desire Disorder in Women

Lisa Larkin, MD, served on the 17-person panel of international of experts

 

The International Society for the Study of Women’s Sexual Health (ISSWSH), the leading multidisciplinary, academic, and scientific organization focused on the study of women’s sexual health, announced today the publication of ISSWSH’s Process of Care for Management of Hypoactive Sexual Desire Disorder (HSDD) in Women in Mayo Clinic Proceedings. This milestone publication is the first to provide a consensus clinical management algorithm for the diagnosis and treatment of HSDD. Dr. Lisa Larkin was one of the 17 international experts to serve on the panel and formulate the guidelines.

 

HSDD is the term for the medical condition of low sexual desire. Women with HSDD experience increased healthcare costs, health burden, and decreased quality of life. HSDD is the most common sexual dysfunction in women, and studies in the U.S. and Europe estimate its prevalence to be 6 – 19%. Recent research and increasing public awareness of HSDD will increase the number of women seeking treatment from healthcare professionals.  The Process of Care for HSDD was developed to meet this unmet need.

 

The process of care algorithm was developed by 17 international expert panelists representing multiple healthcare disciplines and clinical specialties to provide evidence-based guidelines for the identification, diagnosis and treatment of HSDD in women that can be followed by both non-expert primary care professionals and sexual medicine experts.